Experimental and clinical studies of radiosensitizers in brain tumors, with special reference to BUdR-antimetabolite continuous regional infusion-radiation therapy (BAR therapy).
D000328:Adult; D000963:Antimetabolites / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy*; D001973:Bromodeoxyuridine / Q000627:therapeutic use*; D046508:Culture Techniques; D006801:Humans; D007269:Injections, Intra-Arterial; D008297:Male; D011838:Radiation-Sensitizing Agents
D000963:Antimetabolites; D011838:Radiation-Sensitizing Agents; D001973:Bromodeoxyuridine